SE9904377D0 - Pharmaceutical combinations - Google Patents
Pharmaceutical combinationsInfo
- Publication number
- SE9904377D0 SE9904377D0 SE9904377A SE9904377A SE9904377D0 SE 9904377 D0 SE9904377 D0 SE 9904377D0 SE 9904377 A SE9904377 A SE 9904377A SE 9904377 A SE9904377 A SE 9904377A SE 9904377 D0 SE9904377 D0 SE 9904377D0
- Authority
- SE
- Sweden
- Prior art keywords
- pharmaceutical combinations
- combinations
- present
- pharmaceutical
- provides novel
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (37)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9904377A SE9904377D0 (sv) | 1999-12-01 | 1999-12-01 | Pharmaceutical combinations |
ARP000106143A AR033658A1 (es) | 1999-12-01 | 2000-11-21 | Kit de componentes, metodo para el tratamiento de la trombosis,uso de un antagonista del receptor p2t en la elaboracion de un kit de componentes para el tratamiento de la trombosis, formulacion farmaceutica, uso de la formulacion farmaceutica en la elaboracion de un medicamento para el tratamiento d |
PT00982033T PT1237559E (pt) | 1999-12-01 | 2000-11-29 | Combinacoes farmaceuticas compreendendo um antagonista do receptor p2t e megalatrano |
PL355841A PL203430B1 (pl) | 1999-12-01 | 2000-11-29 | Zestaw leczniczy zawieraj acy antagonist e receptora P2T, zastosowanie antagonisty receptora P2T, preparat farmaceutyczny zawieraj acy antagonist e receptora P2T |
DK00982033T DK1237559T3 (da) | 1999-12-01 | 2000-11-29 | Farmaceutiske kombinationer som omfatter en P2T-receptor-antagonist og melagatran |
SI200030885T SI1237559T1 (sl) | 1999-12-01 | 2000-11-29 | Farmacevtska kombinacija vsebujoca p2t receptor antagonist in melagatran |
IL14949500A IL149495A0 (en) | 1999-12-01 | 2000-11-29 | Pharmaceutical formulations comprising p2t receptor antagonist and anti-thrombotic agent and use thereof in therapy |
MYPI20005578A MY128896A (en) | 1999-12-01 | 2000-11-29 | Pharmaceutical combinations |
CN00816374A CN1402639A (zh) | 1999-12-01 | 2000-11-29 | 药用组合物 |
CO00091389A CO5271717A1 (es) | 1999-12-01 | 2000-11-29 | Combinaciones farmaceuticas |
US10/148,526 US20030032618A1 (en) | 1999-12-01 | 2000-11-29 | Pharmaceutical combinations |
EP00982033A EP1237559B1 (en) | 1999-12-01 | 2000-11-29 | Pharmaceutical combinations comprising a p2t receptor antagonist and melagatran |
ES00982033T ES2267591T3 (es) | 1999-12-01 | 2000-11-29 | Combinaciones farmaceuticas que comprenden un antagonista del receptor p2t y melagatran. |
BR0016043-1A BR0016043A (pt) | 1999-12-01 | 2000-11-29 | Kit de partes, método para tratar trombose, uso de um antagonista de receptor p2t ou de um seu derivado farmaceuticamente aceitável, formulação farmacêutica, uso desta, processo para prepará-la, e, uso de um composto de fórmula ou de um seu derivado farmaceuticamente aceitável |
EEP200200271A EE05127B1 (et) | 1999-12-01 | 2000-11-29 | Osadest koosnev komplekt ja ravimpreparaat, mis sisaldavad P2T-retseptori antagonisti v?i selle farmatseutiliselt vastuv?etavat derivaati ja tromboosivastast ainet, ning nende kasutamine meditsiinis |
AU19109/01A AU781691B2 (en) | 1999-12-01 | 2000-11-29 | Pharmaceutical combinations |
CA2391161A CA2391161C (en) | 1999-12-01 | 2000-11-29 | Pharmaceutical combinations comprising a p2t receptor antagonist and an anti-thrombotic agent |
NZ518904A NZ518904A (en) | 1999-12-01 | 2000-11-29 | A pharmaceutical composition comprising a P2T receptor antagonist, or a pharmaceutically acceptable salt thereof, and an anti-thrombotic agent, and the use of the combination in the treatment and prevention of thrombosis |
PCT/SE2000/002378 WO2001039781A1 (en) | 1999-12-01 | 2000-11-29 | Pharmaceutical combinations |
CZ20021887A CZ300925B6 (cs) | 1999-12-01 | 2000-11-29 | Kit ze soucástí pro antitrombotickou terapii, antagonista receptoru P2T, farmaceutický prostredek a lécivo pro lécení trombózy |
JP2001541513A JP2003515565A (ja) | 1999-12-01 | 2000-11-29 | 薬剤の組合せ |
KR1020027007026A KR100785953B1 (ko) | 1999-12-01 | 2000-11-29 | 약학 조합제제 |
MXPA02004871A MXPA02004871A (es) | 1999-12-01 | 2000-11-29 | Combinaciones farmaceuticas. |
NZ530058A NZ530058A (en) | 1999-12-01 | 2000-11-29 | A pharmaceutical combination comprising a P2T receptor antagonist, or a pharmaceutically acceptable salt thereof, and an anti-thrombotic agent, and the use of the combination in the treatment and prevention of thrombosis |
EP06075955A EP1719526A3 (en) | 1999-12-01 | 2000-11-29 | Pharmaceutical combinations comprising a P2T receptor antagonist and another anti-thrombotic agent |
HU0203585A HU230890B1 (hu) | 1999-12-01 | 2000-11-29 | Egy P2T receptor antagonistát és melagatrant tartalmazó gyógyszerkombinációk |
SK750-2002A SK288707B6 (sk) | 1999-12-01 | 2000-11-29 | Farmaceutické kombinácie obsahujúce antagonistu P2T receptora a ďalšie antitrombotické činidlá, spôsob ich prípravy a ich použitie na liečenie a prevenciu trombózy |
DE60029340T DE60029340T2 (de) | 1999-12-01 | 2000-11-29 | Pharmazeutische zusammenstellungen enthaltend einen p2t rezeptor antagonist und melagatran |
AT00982033T ATE332698T1 (de) | 1999-12-01 | 2000-11-29 | Pharmazeutische zusammenstellungen enthaltend einen p2t rezeptor antagonist und melagatran |
RU2002117296/15A RU2242232C2 (ru) | 1999-12-01 | 2000-11-29 | Фармацевтические комбинации |
TW089125873A TWI251491B (en) | 1999-12-01 | 2000-12-05 | Pharmaceutical combinations |
ZA200203707A ZA200203707B (en) | 1999-12-01 | 2002-05-09 | Pharmaceutical combinations. |
IS6398A IS2841B (is) | 1999-12-01 | 2002-05-27 | Samstæða hluta og lyfjasamsetningar |
NO20022606A NO331215B1 (no) | 1999-12-01 | 2002-05-31 | Kit av deler og farmasoytiske formuleringer |
HK03100127A HK1047893A1 (en) | 1999-12-01 | 2003-01-06 | Pharmaceutical combinations comprising a p2t receptor antagonist and melagatran |
US11/441,278 US20060270607A1 (en) | 1999-12-01 | 2006-05-25 | Pharmaceutical combinations |
CY20061101267T CY1105211T1 (el) | 1999-12-01 | 2006-09-05 | Φαρμακευτικοι συνδυασμοι που πepιλαμβανουν εναν ανταγωνιστη του υποδοχεα p2τ και μελαγατρανη |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9904377A SE9904377D0 (sv) | 1999-12-01 | 1999-12-01 | Pharmaceutical combinations |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9904377D0 true SE9904377D0 (sv) | 1999-12-01 |
Family
ID=20417947
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9904377A SE9904377D0 (sv) | 1999-12-01 | 1999-12-01 | Pharmaceutical combinations |
Country Status (33)
Country | Link |
---|---|
US (2) | US20030032618A1 (sv) |
EP (2) | EP1719526A3 (sv) |
JP (1) | JP2003515565A (sv) |
KR (1) | KR100785953B1 (sv) |
CN (1) | CN1402639A (sv) |
AR (1) | AR033658A1 (sv) |
AT (1) | ATE332698T1 (sv) |
AU (1) | AU781691B2 (sv) |
BR (1) | BR0016043A (sv) |
CA (1) | CA2391161C (sv) |
CO (1) | CO5271717A1 (sv) |
CY (1) | CY1105211T1 (sv) |
CZ (1) | CZ300925B6 (sv) |
DE (1) | DE60029340T2 (sv) |
DK (1) | DK1237559T3 (sv) |
EE (1) | EE05127B1 (sv) |
ES (1) | ES2267591T3 (sv) |
HK (1) | HK1047893A1 (sv) |
HU (1) | HU230890B1 (sv) |
IL (1) | IL149495A0 (sv) |
IS (1) | IS2841B (sv) |
MX (1) | MXPA02004871A (sv) |
MY (1) | MY128896A (sv) |
NO (1) | NO331215B1 (sv) |
NZ (2) | NZ518904A (sv) |
PT (1) | PT1237559E (sv) |
RU (1) | RU2242232C2 (sv) |
SE (1) | SE9904377D0 (sv) |
SI (1) | SI1237559T1 (sv) |
SK (1) | SK288707B6 (sv) |
TW (1) | TWI251491B (sv) |
WO (1) | WO2001039781A1 (sv) |
ZA (1) | ZA200203707B (sv) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7452870B2 (en) | 2000-08-21 | 2008-11-18 | Inspire Pharmaceuticals, Inc. | Drug-eluting stents coated with P2Y12 receptor antagonist compound |
US7132408B2 (en) | 2000-08-21 | 2006-11-07 | Inspire Pharmaceuticals, Inc. | Composition and method for inhibiting platelet aggregation |
US6897201B2 (en) | 2000-08-21 | 2005-05-24 | Inspire Pharmaceuticals, Inc. | Compositions and methods for the treatment of glaucoma or ocular hypertension |
US7018985B1 (en) | 2000-08-21 | 2006-03-28 | Inspire Pharmaceuticals, Inc. | Composition and method for inhibiting platelet aggregation |
US7115585B2 (en) | 2000-08-21 | 2006-10-03 | Inspire Pharmaceuticals, Inc. | Compositions for treating epithelial and retinal tissue diseases |
DE10064797A1 (de) * | 2000-12-22 | 2002-06-27 | Knoll Ag | Orale und parenterale pharmazeutische Formulierung, umfassend eine niedermolekulare Thrombininhibitor-Pro-Pharmakon |
SE0101932D0 (sv) * | 2001-05-31 | 2001-05-31 | Astrazeneca Ab | Pharmaceutical combinations |
US7435724B2 (en) | 2002-02-27 | 2008-10-14 | Inspire Pharmaceutical, Inc. | Degradation-resistant mononucleoside phosphate compounds |
EP1604669A1 (en) * | 2004-06-10 | 2005-12-14 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Use of ATP analogues for treatment of cardiovascular diseases |
KR100736024B1 (ko) * | 2005-09-21 | 2007-07-06 | 주식회사종근당 | 신규한 클로피도그렐 우선성 광학이성체의 이온교환수지착체와 그 제조방법 |
US9427448B2 (en) | 2009-11-11 | 2016-08-30 | The Medicines Company | Methods of treating, reducing the incidence of, and/or preventing ischemic events |
WO2009140092A1 (en) | 2008-05-13 | 2009-11-19 | The Medicines Company | Maintenance of platelet inhibition during antiplatelet therapy |
US20130303477A1 (en) | 2008-05-13 | 2013-11-14 | The Medicines Company | Maintenance of Platelet Inhibition During Antiplatelet Therapy |
US8759316B2 (en) | 2008-05-13 | 2014-06-24 | The Medicines Company | Maintenance of platelet inhibition during antiplatelet therapy |
US20120141468A1 (en) | 2008-05-13 | 2012-06-07 | Lisa Ruderman Chen | Maintenance of platelet inhibition during antiplatelet therapy |
US10376532B2 (en) | 2009-11-11 | 2019-08-13 | Chiesi Farmaceutici, S.P.A. | Methods of treating, reducing the incidence of, and/or preventing ischemic events |
PL2498731T3 (pl) | 2009-11-11 | 2020-07-13 | Chiesi Farmaceutici S.P.A. | Sposoby leczenia lub zapobiegania zakrzepicy w stencie |
CN103582480B (zh) | 2011-02-09 | 2016-03-16 | 医药公司 | 治疗肺高压的方法 |
PL2964233T3 (pl) | 2013-03-09 | 2022-04-25 | Chiesi Farmaceutici S.P.A. | Sposoby leczenia, zmniejszania częstości występowania i(lub) profilaktyki zdarzeń niedokrwiennych |
KR20200018481A (ko) | 2017-06-23 | 2020-02-19 | 키에시 파르마슈티시 엣스. 피. 에이. | 체폐동맥 션트 혈전증의 예방 방법 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8826448D0 (en) * | 1988-11-11 | 1988-12-14 | Thrombosis Res Inst | Improvements in/relating to organic compounds |
DK0508687T3 (da) * | 1991-04-06 | 1996-02-05 | Astra Pharma Prod | ATP-analoger |
HU221501B (en) * | 1993-02-10 | 2002-10-28 | Astrazeneca Ab | N-alkyl-2-substituted atp analogues |
MA23420A1 (fr) * | 1994-01-07 | 1995-10-01 | Smithkline Beecham Corp | Antagonistes bicycliques de fibrinogene. |
SE9404196D0 (sv) * | 1994-12-02 | 1994-12-02 | Astra Ab | New antithrombotic formulation |
DE69621021T2 (de) * | 1995-07-11 | 2002-10-31 | Astrazeneca Ab | Inhibitoren der plättchenaggregation |
ES2246575T3 (es) * | 1998-06-17 | 2006-02-16 | Bristol-Myers Squibb Company | Prevencion del infarto cerebral mediante la administracion de una combinacion de un farmaco antiplaquetario bloqueador del receptor adp y un farmaco antihipertensivo. |
SE9802973D0 (sv) * | 1998-09-03 | 1998-09-03 | Astra Ab | Immediate release tablet |
TWI229674B (en) * | 1998-12-04 | 2005-03-21 | Astra Pharma Prod | Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses |
US6462021B1 (en) * | 2000-11-06 | 2002-10-08 | Astrazeneca Ab | Use of low molecular weight thrombin inhibitor |
US6696468B2 (en) * | 2002-05-16 | 2004-02-24 | Dainippon Pharmaceutical Co., Ltd. | (s)-4-amino-5-chloro-2-methoxy-n-[1-[1-(2-tetrahydrofuryl-carbonyl)-4-piperidinylmethyl]-4-piperidinyl]benzamide, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor |
US20040067995A1 (en) * | 2002-10-02 | 2004-04-08 | Wong Pancras C. | Novel combination of a factor Xa inhibitor and clopidogrel |
CA2532805A1 (en) * | 2003-07-16 | 2005-01-27 | Kyowa Hakko Kogyo Co., Ltd. | Pharmaceutical composition |
-
1999
- 1999-12-01 SE SE9904377A patent/SE9904377D0/sv unknown
-
2000
- 2000-11-21 AR ARP000106143A patent/AR033658A1/es unknown
- 2000-11-29 DK DK00982033T patent/DK1237559T3/da active
- 2000-11-29 EP EP06075955A patent/EP1719526A3/en not_active Withdrawn
- 2000-11-29 RU RU2002117296/15A patent/RU2242232C2/ru active
- 2000-11-29 AT AT00982033T patent/ATE332698T1/de active
- 2000-11-29 HU HU0203585A patent/HU230890B1/hu unknown
- 2000-11-29 EP EP00982033A patent/EP1237559B1/en not_active Expired - Lifetime
- 2000-11-29 WO PCT/SE2000/002378 patent/WO2001039781A1/en active IP Right Grant
- 2000-11-29 SK SK750-2002A patent/SK288707B6/sk not_active IP Right Cessation
- 2000-11-29 PT PT00982033T patent/PT1237559E/pt unknown
- 2000-11-29 IL IL14949500A patent/IL149495A0/xx unknown
- 2000-11-29 EE EEP200200271A patent/EE05127B1/xx unknown
- 2000-11-29 BR BR0016043-1A patent/BR0016043A/pt not_active Application Discontinuation
- 2000-11-29 MY MYPI20005578A patent/MY128896A/en unknown
- 2000-11-29 NZ NZ518904A patent/NZ518904A/en not_active IP Right Cessation
- 2000-11-29 KR KR1020027007026A patent/KR100785953B1/ko not_active IP Right Cessation
- 2000-11-29 CZ CZ20021887A patent/CZ300925B6/cs not_active IP Right Cessation
- 2000-11-29 ES ES00982033T patent/ES2267591T3/es not_active Expired - Lifetime
- 2000-11-29 JP JP2001541513A patent/JP2003515565A/ja not_active Ceased
- 2000-11-29 DE DE60029340T patent/DE60029340T2/de not_active Expired - Lifetime
- 2000-11-29 CO CO00091389A patent/CO5271717A1/es not_active Application Discontinuation
- 2000-11-29 AU AU19109/01A patent/AU781691B2/en not_active Expired
- 2000-11-29 NZ NZ530058A patent/NZ530058A/en not_active IP Right Cessation
- 2000-11-29 CA CA2391161A patent/CA2391161C/en not_active Expired - Lifetime
- 2000-11-29 SI SI200030885T patent/SI1237559T1/sl unknown
- 2000-11-29 US US10/148,526 patent/US20030032618A1/en not_active Abandoned
- 2000-11-29 CN CN00816374A patent/CN1402639A/zh active Pending
- 2000-11-29 MX MXPA02004871A patent/MXPA02004871A/es active IP Right Grant
- 2000-12-05 TW TW089125873A patent/TWI251491B/zh not_active IP Right Cessation
-
2002
- 2002-05-09 ZA ZA200203707A patent/ZA200203707B/xx unknown
- 2002-05-27 IS IS6398A patent/IS2841B/is unknown
- 2002-05-31 NO NO20022606A patent/NO331215B1/no not_active IP Right Cessation
-
2003
- 2003-01-06 HK HK03100127A patent/HK1047893A1/xx not_active IP Right Cessation
-
2006
- 2006-05-25 US US11/441,278 patent/US20060270607A1/en not_active Abandoned
- 2006-09-05 CY CY20061101267T patent/CY1105211T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9904377D0 (sv) | Pharmaceutical combinations | |
DK0960107T3 (da) | 6-Thiosubstituerede paclitaxeler | |
CO5611160A2 (es) | Conjugados de agentes terapeuticos o citotoxicos y peptidos biologicamente activos | |
NO996269D0 (no) | Quinolin-indol antimikrobielle midler, samt anvendelse og blandinger derav | |
ATE231872T1 (de) | Thiazolopyrimidinderivate | |
CY1112687T1 (el) | Μεθοδος για χρηση δικετοπιπεραζινων και συνθεσεις που περιλαμβανουν αυτες | |
DE69907137D1 (de) | Autoklavierbare pharmazeutische zusammensetzungen mit komplexbildner | |
DE69826683D1 (de) | Therapeutische zusammensetzungen, enthaltend amlopidin und atorvastatin | |
IT1318649B1 (it) | Composizioni farmaceutiche per il trattamento di mucositi e stomatiti. | |
TR200100054T2 (tr) | Paroksetin metansülfonat | |
HK1061212A1 (en) | Pyranoindazoles and their use for the treatment ofglaucoma | |
DE60134126D1 (de) | 17-alpha-substituierte-11-beta-substituierte-4-aryl und 21-substituierte 19-norpregnadienedione mit antigestagener aktivität | |
PT1224205E (pt) | Derivados 5-beta-sapogenina e pseudo-sapogenina e sua utilizacao no tratamento de demencia | |
BR0208971B1 (pt) | produto absorvente com ajuste melhorado. | |
BR0208970B1 (pt) | produto absorvente com ajuste melhorado. | |
NO20005179D0 (no) | Medikament behandling | |
PT1228028E (pt) | Sais de hidroxieicosatetraeniato, composicoes e metodos para utilizacao no tratamento de perturbacoes da secura ocular | |
ATE365748T1 (de) | Polymer-konjugate von neublastin und methoden für deren verwendung | |
SE9802937D0 (sv) | Novel compounds | |
IS7275A (is) | Samsetning fyrir hollegg og notkun á henni | |
BR0012043B1 (pt) | composiÇço de tratamento de cabelo. | |
NO20005548L (no) | Mykobakterieinhibitorer | |
DK1011329T3 (da) | 7-Methylthiooxomethyl- og 7-methylthiodioxomethyl-paclitaxeler | |
NO20021429L (no) | 1,4-dioksacykloalkan-2-oner og 1,4-dioksacykloalken-2-oner | |
ATA17852001A (de) | Signaturarmer und schadstoffreduzierter, pyrotechnischer darstellungskörper |